Difference between revisions of "Hancock S"
From Bioblast
m (moved Hancock Saege to Hancock S over redirect) |
Beno Marija (talk | contribs) ย |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 5: | Line 5: | ||
The Children's Hospital of Philadelphia | The Children's Hospital of Philadelphia | ||
|city=Philadelphia | |||
|state=Pennsylvania (PA) | |||
|country=USA | |||
|info=[[IOC61]] | |info=[[IOC61]] | ||
}} | }} | ||
Line 11: | Line 14: | ||
|info=[[IOC61]] | |info=[[IOC61]] | ||
}} | }} | ||
== Participated at== | |||
::::* [[IOC61| IOC61 Schroecken AT]] |
Latest revision as of 17:51, 12 February 2018
Name | Hancock Saege, |
---|---|
Institution | Center for Mitochondrial and Epigenomic Medicine (CMEM)
The Children's Hospital of Philadelphia |
Address | , |
City | Philadelphia |
State/Province | Pennsylvania (PA) |
Country | USA |
Weblink | |
O2k-Network Lab | US PA Philadelphia Wallace DC |
Labels:
Field of research: Basic
Publications
Add references to your publications
Abstracts
Published | Reference | |
---|---|---|
Picard 2014 Abstract MiP2014 | 2014 | Quantitative regulation of nuclear gene expression by mitochondrial DNA heteroplasmy. |